Know Cancer

or
forgot password

Transbronchial Needle Aspiration With and Without Rapid On-site Cytopathologic Evaluation in the Diagnostic Approach to Hilar/Mediastinal Adenopathy: A Randomized Controlled Trial.


N/A
18 Years
90 Years
Not Enrolling
Both
Lung Cancer, Sarcoidosis, Tuberculosis

Thank you

Trial Information

Transbronchial Needle Aspiration With and Without Rapid On-site Cytopathologic Evaluation in the Diagnostic Approach to Hilar/Mediastinal Adenopathy: A Randomized Controlled Trial.


Inclusion Criteria:



- 18 years old and older

- Hilar and/or mediastinal lymphadenopathy (> 1 cm on the short axis, as assessed by
contrast-enhanced CT scan (computed tomography))

Exclusion Criteria:

- Uncontrolled coagulopathy

- Refusal to sign informed consent

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Examine the diagnostic yield of the TBNA with ROSE arm versus the diagnostic yield of TBNA alone arm

Outcome Time Frame:

6-12 months

Safety Issue:

No

Principal Investigator

Marco Patelli, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Maggiore Hospital

Authority:

Italy: Ethics Committee

Study ID:

01-Trisolini

NCT ID:

NCT00915330

Start Date:

May 2009

Completion Date:

February 2010

Related Keywords:

  • Lung Cancer
  • Sarcoidosis
  • Tuberculosis
  • Transbronchial needle aspiration
  • Bronchoscopy
  • Rapid on-site cytopathologic evaluation
  • Mediastinal lymphadenopathy
  • Hilar Lymphadenopathy
  • Lung Neoplasms
  • Sarcoidosis
  • Tuberculosis

Name

Location